Abivax S.A. — Investor Relations & Filings
Abivax S.A. is a clinical-stage biotechnology company focused on developing therapeutics for chronic inflammatory diseases by harnessing the body's natural regulatory mechanisms. The company's core strategy revolves around modulating the immune response through microRNA (miRNA). Its lead drug candidate, obefazimod, is an investigational, orally administered small molecule with a novel mechanism of action. Obefazimod is designed to enhance the expression of miR-124, a key microRNA that regulates the inflammatory response. The primary development goal is the commercialization of obefazimod for the treatment of ulcerative colitis, with clinical programs also underway for Crohn's disease. The company is exploring obefazimod for other inflammatory indications and is investigating follow-on compounds from its proprietary chemical library.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2026-05-22 | English | |
| 6-K | 2026-05-20 | English | |
| 6-K - Abivax S.A. (0001956827) (Filer) | 2026-05-07 | English | |
| 424B7 - Abivax S.A. (0001956827) (Filer) | 2026-05-07 | English | |
| S-8 - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | |
| 20-F - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 46859106 | 6-K | 2026-05-22 | English | ||
| 46692793 | 6-K | 2026-05-20 | English | ||
| 43481539 | 6-K - Abivax S.A. (0001956827) (Filer) | 2026-05-07 | English | ||
| 43132807 | 424B7 - Abivax S.A. (0001956827) (Filer) | 2026-05-07 | English | ||
| 33016665 | S-8 - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 33016505 | 20-F - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 33016424 | 6-K - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 32249312 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 13630008 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 13630005 | Regulatory Filings 2026 | 2026-01-08 | English | ||
|
2025
5 filings
| |||||
| 13630007 | 6-K | 2025-12-15 | English | ||
| 13630010 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13630009 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13630012 | Major Shareholding Notification 2025 | 2025-10-30 | English | ||
| 13630011 | Regulatory Filings 2025 | 2025-10-28 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Blueberries Medical Corp.
Licensed producer of science-based wellness products derive…
|
BBM | CA | Manufacturing |
|
Blue Jet Healthcare Limited
CDMO specializing in contrast media intermediates, sweetene…
|
BLUEJET | IN | Manufacturing |
|
BNC Korea Co, Ltd
Develops hyaluronic acid-based dermal fillers and botulinum…
|
256840 | KR | Manufacturing |
|
Boditech Med Inc.
Develops, manufactures, and distributes in-vitro diagnostic…
|
206640 | KR | Manufacturing |
|
BOIRON
A family-owned pharmaceutical laboratory and a world leader…
|
BOI | FR | Manufacturing |
|
BOLAK CO.,LTD
Manufactures specialty ingredients for the food, pharmaceut…
|
002760 | KR | Manufacturing |
|
Bolt Biotherapeutics, Inc.
Clinical-stage biotech developing immuno-oncology therapies…
|
BOLT | US | Manufacturing |
|
Bone Biologics Corp
Develops a protein-based bone graft substitute for spinal f…
|
BBLG | US | Manufacturing |
|
Bonyf N.V.
Develops medical devices for oral, dental, orthodontic, and…
|
MLBON | BE | Manufacturing |
|
Bora
Global pharmaceutical provider of CDMO services and special…
|
6472 | TW | Manufacturing |
Abivax S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30868/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30868 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30868 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30868 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30868}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abivax S.A. (id: 30868)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.